CTI BIOPHARMA CORP (CTIC)       5.99  +0.01 (+0.17%)

5.99  +0.01 (+0.17%)

US12648L6011 - Common Stock - After market: 5.93 -0.06 (-1%)

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
32.87M0.000.003.35M26.29M
Non Recurring Items
N/A-138.00K-4.20M-790.00K-660.00K
Minority Interest Expense
N/AN/A0.000.0030.00K
Cost Of Goods
N/AN/AN/AN/A880.00K
Gross Profit
N/AN/AN/AN/A25.41M
Operating Expenses
132.09M95.33M43.57M43.27M57.65M
Operating Income
N/AN/AN/AN/A-32.24M
Interest Expense
-10.82M-2.44M-910.00K-630.00K-750.00K
Income Before Taxes
-112.32M-97.91M-52.45M-40.02M-29.35M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-112.32M-97.91M-52.45M-40.02M-29.32M
EBITDA
N/AN/AN/AN/A-31.65M
 
Per Share Data
EPS Diluted Total Ops
-1.09-1.09-0.74-0.69-0.52
Non GAAP EPS
-1.09-1.08-0.69-0.69-0.52
 
Statistics
Gross Profit Margin
N/AN/AN/AN/A96.65%
Profit Margin
-341.77%N/AN/A-1194.63%-111.53%
Operating Profit Margin
N/AN/AN/AN/A-122.63%

All data in USD

Charts